Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial
Sungkyunkwan University · Samsung Medical Center · +26 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
69
total citations
- FWCI
- 77.06
- Percentile
- 100%
- References
- 32
Citations per year
Authors
35- KHKi Hong ChoiCorresponding
Sungkyunkwan University, Samsung Medical Center
- YHYong Hwan Park
Sungkyunkwan University, Samsung (South Korea)
- JLJong‐Young Lee
Samsung Medical Center, Sungkyunkwan University, Kangbuk Samsung Hospital, Daegu Catholic University Medical Center
- JJJin‐Ok Jeong
Chungnam National University Hospital
- CJChan Joon Kim
Topics & keywords
Topics
Keywords
- Medicine
- Clopidogrel
- Aspirin
- Percutaneous coronary intervention
- Cardiovascular event
- Internal medicine
- Randomized controlled trial
- Open label
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.